Tailoring Treatment Approaches in Psoriasis Management - Episode 1
Challenges in Defining Psoriasis Severity in Clinical Practice
Panelists discuss how despite multiple psoriasis severity measurements having clinical value—body surface area (BSA) providing quick area estimates but lacking quality assessment, psoriasis area and severity index (PASI) offering comprehensive scoring but requiring training, Physician Global Assessment (PGA) delivering simple standardized physician evaluations with potential inconsistency, and patient-reported outcomes capturing critical quality-of-life impacts often missed by clinical metrics—each measure has distinct limitations that necessitate using complementary approaches for optimal treatment planning.
Video content above is prompted by the following:
- There are several measures of severity utilized in the management of psoriasis. Briefly discuss the clinical utility as well as limitations of some of these measures.
- BSA
- PASI
- PGA
- Patient-reported outcomes
